• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions

tetano

Editor, Senior Moderator
J Infect Dis. 2016 Oct 12. pii: jiw471. [Epub ahead of print]
[h=1]Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.[/h] Liu WJ[SUP]1[/SUP], Tan S[SUP]2[/SUP], Zhao M[SUP]2[/SUP], Quan C[SUP]3[/SUP], Bi Y[SUP]4[/SUP], Wu Y[SUP]4[/SUP], Zhang S[SUP]4[/SUP], Zhang H[SUP]5[/SUP], Xiao H[SUP]6[/SUP], Qi J[SUP]4[/SUP], Yan J[SUP]4[/SUP], Liu W[SUP]4[/SUP], Yu H[SUP]7[/SUP], Shu Y[SUP]3[/SUP], Wu G[SUP]3[/SUP], Gao GF[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h]  The emergence of infections by the novel avian influenza A (H7N9) virus has posed a threat to human health. Cross-immunity between H7N9 and other heterosubtypic influenza viruses affected by antigenicity-dependent substitutions needs to be investigated.
[h=4]METHODS:[/h]  We investigated the cellular and humoral immune responses against H7N9 and the 2009 pandemic H1N1 influenza viruses, by serological and T-cell-specific assays in a healthy population. The molecular bases of the cellular and humoral antigenic variability of H7N9 were illuminated by structural determination.
[h=4]RESULTS:[/h]  We not only found antibodies against H7N9 were lacking in the studied population, but also revealed both CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cells that cross-reacted with H7N9 were at significantly lower levels than those against the 2009pH1N1 peptides with substitutions. Moreover, individual peptides for the H7N9 virus with low cross-reactivity were identified. Structural determination indicated that substitutions within these peptides influence the antigenic variability of H7N9 through both major histocompatibility complex (MHC)-binding and T-cell receptor (TCR)-docking.
[h=4]CONCLUSIONS:[/h]  The impact of antigenicity-dependent substitutions on cross-reactivity of T-cell immunity against the novel H7N9 virus in the healthy population benefits the understanding of immune evasion of influenza viruses and provides a useful reference for universal vaccine development.
? The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.


PMID: 27738054 DOI: 10.1093/infdis/jiw471
[PubMed - as supplied by publisher]
 
Back
Top Bottom